Reuters: Hims to stop offering GLP-1 pill after FDA warned of crackdown
FDA on Friday said it would restrict GLP-1 ingredients Novo, Lilly shares fell after Hims launched the pill on Thursday Hims said the decision followed discussions with stakeholders "Since launching ...
MSN: Hims & Hers halts knockoff Wegovy pill after just two days: Here's why
Hims & Hers HealthHIMS, facing an FDA crackdown, announced Saturday that it has stopped offering a new compounded copycat of oral Wegovy, the weight-loss pill made by Novo NordiskNVO. Him & Hers stock ...
Hims & Hers halts knockoff Wegovy pill after just two days: Here's why
Yahoo: Analysis-Hims' $49 weight-loss pill rattles investor case for cash-pay obesity market
LONDON, Feb 6 (Reuters) - Hims & Hers' gambit to sell a $49 compounded version of Novo Nordisk's Wegovy pill is rattling obesity shares, sparking debate about the legality of the move and threatening ...
AOL: Hims Withdraws GLP-1 Weight Loss Pill After FDA Warning and Lawsuit Threats
Hims Withdraws GLP-1 Weight Loss Pill After FDA Warning and Lawsuit Threats
KSL: Hims & Hers launches Wegovy knockoff pill; Novo Nordisk vows to sue
WASHINGTON — Telehealth company Hims & Hers said Thursday it will launch a cheaper, off-brand version of the weight loss pill Wegovy, just weeks after drugmaker Novo Nordisk launched its highly ...
Hims & Hers launches Wegovy knockoff pill; Novo Nordisk vows to sue
Yahoo: Hims Pulls GLP-1 Weight Loss Pill Two Days After Announcing It
AOL: Analysis-Hims & Hers GLP-1 pill gambit backfires, accelerating crackdown on drug compounders
Analysis-Hims & Hers GLP-1 pill gambit backfires, accelerating crackdown on drug compounders